Zacks Research Analysts Reduce Earnings Estimates for Ovintiv Inc. (NYSE:OVV)

Ovintiv Inc. (NYSE:OVVFree Report) – Investment analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for Ovintiv in a report released on Wednesday, June 26th. Zacks Research analyst R. Department now anticipates that the company will earn $1.26 per share for the quarter, down from their prior estimate of $1.27. The consensus estimate for Ovintiv’s current full-year earnings is $6.11 per share.

Ovintiv (NYSE:OVVGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $1.44 EPS for the quarter, beating analysts’ consensus estimates of $1.32 by $0.12. The firm had revenue of $2.35 billion during the quarter, compared to the consensus estimate of $2.58 billion. Ovintiv had a return on equity of 17.74% and a net margin of 18.12%.

Several other brokerages have also recently issued reports on OVV. Morgan Stanley upped their price objective on Ovintiv from $49.00 to $53.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. Jefferies Financial Group upped their price objective on Ovintiv from $59.00 to $69.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Barclays assumed coverage on Ovintiv in a research note on Wednesday, April 10th. They set an “overweight” rating and a $69.00 price objective on the stock. The Goldman Sachs Group upped their price objective on Ovintiv from $47.00 to $56.00 and gave the company a “neutral” rating in a research note on Tuesday, March 26th. Finally, TD Cowen upped their price objective on Ovintiv from $64.00 to $66.00 and gave the company a “buy” rating in a research note on Monday, June 10th. Five analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $58.65.

Read Our Latest Analysis on Ovintiv

Ovintiv Trading Up 0.1 %

Shares of OVV opened at $46.94 on Monday. The company has a market capitalization of $12.53 billion, a P/E ratio of 6.56 and a beta of 2.58. Ovintiv has a one year low of $36.27 and a one year high of $55.95. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.52 and a current ratio of 0.52. The stock has a 50-day moving average price of $49.14 and a 200 day moving average price of $47.59.

Ovintiv Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 2.56%. The ex-dividend date of this dividend was Friday, June 14th. Ovintiv’s dividend payout ratio is currently 16.76%.

Insider Activity at Ovintiv

In related news, Director Howard John Mayson sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $51.14, for a total value of $204,560.00. Following the sale, the director now directly owns 45,279 shares in the company, valued at approximately $2,315,568.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, Director Howard John Mayson sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $51.14, for a total value of $204,560.00. Following the sale, the director now directly owns 45,279 shares in the company, valued at approximately $2,315,568.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Steven W. Nance sold 12,000 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $50.00, for a total value of $600,000.00. Following the completion of the sale, the director now owns 8,929 shares in the company, valued at $446,450. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Ovintiv

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Ovintiv by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 28,055,344 shares of the company’s stock valued at $1,456,072,000 after purchasing an additional 1,024,931 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Ovintiv by 6.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,639,579 shares of the company’s stock valued at $115,937,000 after purchasing an additional 168,320 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Ovintiv by 4.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,676,420 shares of the company’s stock valued at $73,628,000 after purchasing an additional 68,718 shares in the last quarter. Ceredex Value Advisors LLC bought a new position in Ovintiv during the 4th quarter valued at $67,149,000. Finally, Balyasny Asset Management L.P. boosted its stake in Ovintiv by 1,560.9% during the 4th quarter. Balyasny Asset Management L.P. now owns 1,451,240 shares of the company’s stock valued at $63,738,000 after purchasing an additional 1,363,865 shares in the last quarter. 83.81% of the stock is owned by institutional investors.

About Ovintiv

(Get Free Report)

Ovintiv Inc, together with its subsidiaries, explores, develops, produces, and markets natural gas, oil, and natural gas liquids in the United States and Canada. The company operates through USA Operations, Canadian Operations, and Market Optimization segments. Its principal assets include Permian in west Texas and Anadarko in west-central Oklahoma; and Montney in northeast British Columbia and northwest Alberta.

Featured Stories

Earnings History and Estimates for Ovintiv (NYSE:OVV)

Receive News & Ratings for Ovintiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovintiv and related companies with MarketBeat.com's FREE daily email newsletter.